Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CWAN vs DSGX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CWAN Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–5 Matrix Metrics)

CWAN Overall Winner 6-Pillar Tally: CWAN 3 – 3 DSGX Matrix Metrics: CWAN 5 – 5 DSGX

As of Nov 20, 2026, Clearwater Analytics Holdings, Inc. (CWAN) is the stronger overall head-to-head candidate over Descartes Systems Group Inc (DSGX) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning, R&D & Supply-Chain Moat). CWAN carries a Unified Composite Score of 63.2/100 (BUY) at $24.56 (94.5x Forward P/E, 4.1% operating margin), whereas DSGX carries 40.1/100 (SELL) at $89.20 (34.2x Forward P/E, 32.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CWAN vs DSGX
CWAN NYSE Head-to-Head Winner
Clearwater Analytics Holdings, Inc.
Services-Prepackaged Software
$24.56
+0.04% 1D
Market Cap $7.3B
TTM Revenue $826M
Forward P/E 94.5x
Beta / 30D Vol 0.42β · 4% Vol
Unified Composite Score
63.2 / 100 BUY
Tech 75.0 Fund 62.0 Flow 69.0 Mom 29.5
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.3% over 20 days), RSI 68
RSI-14: 67.9 · SMA20: $24.38 · SMA50: $24.29
DSGX NASDAQ
Descartes Systems Group Inc
Services-Prepackaged Software
$89.20
-0.77% 1D
Market Cap $7.7B
TTM Revenue $775M
Forward P/E 34.2x
Beta / 30D Vol 0.27β · 23% Vol
Unified Composite Score
40.1 / 100 SELL
Tech 36.0 Fund 48.0 Flow 65.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 45.6 · SMA20: $93.06 · SMA50: $86.90

6-Pillar Scorecard Institutional Category Breakdown (CWAN 3 – 3 DSGX)

Columns: Metric · CWAN · DSGX
1. Valuation Multiples DSGX
Forward P/E 94.5x 34.2x
Trailing P/E 35.6x 41.8x
PEG Ratio 1.78x 1.53x
EV / Revenue 8.9x 9.4x
2. Growth & Scale CWAN
Revenue Growth (YoY) +74.4% +11.8%
Earnings Growth (YoY) +202.8% +32.6%
TTM Revenue (USD) $826M $775M
Market Cap $7.3B $7.7B
3. Profitability & Quality DSGX
Gross Margin 66.0% 77.6%
Operating Margin 4.1% 32.0%
Net Profit Margin -5.8% 24.2%
Return on Equity (ROE) -3.1% 11.9%
4. Balance Sheet & Cash Flow DSGX
Cash Generation (TTM) $109M EBITDA $299M
Cash Flow Margin 13.2% EBITDA Mgn 38.5%
Net Cash / Leverage $6.89 Book/Sh · -3.1% ROE $394M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CWAN
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 0.8% (<1st %ile) 42.6% (13th %ile)
Put/Call OI Skew N/A 0.20x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat CWAN
OpEx & R&D Intensity 61.9% of Rev ($511M) 45.6% of Rev ($353M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Software - Application Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CWAN (5) vs DSGX (5)
Institutional Metric CWAN DSGX Criterion Row Edge
Market Capitalization
Scale
$7.3B $7.7B Larger Scale DSGX
Trailing P/E Ratio
Valuation
35.6x 41.8x Lower Multiple CWAN
Forward P/E Ratio
Valuation
94.5x 34.2x Lower Multiple DSGX
Revenue Growth (YoY)
Growth
+74.4% +11.8% Higher Growth CWAN
Operating Margin (TTM)
Profitability
4.1% 32.0% Higher Margin DSGX
Net Profit Margin
Profitability
-5.8% 24.2% Higher Margin DSGX
Return on Equity (ROE)
Capital Efficiency
-3.1% 11.9% Higher ROE DSGX
52-Week Range Position
Momentum
100% ($16–$25) 78% ($63–$97) Stronger Trend CWAN
Beta / 30D Volatility
Risk Regime
0.42β · 4% Vol 0.27β · 23% Vol Lower Realized Risk CWAN
Unified Institutional Score
Composite Signal
63.2 / 100 (BUY) 40.1 / 100 (SELL) Higher Composite CWAN
Trailing 12M Revenue (USD)
Operating Scale
$826M $775M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
66.0% 77.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.78x PEG · 8.9x EV/Rev 1.53x PEG · 9.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$109M EBITDA ($6.89 Book/Sh · -3.1% ROE) $299M ($394M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CWAN +5.93 pp
CWAN: +0.99% · DSGX: -4.94%
3M Horizon CWAN +10.41 pp
CWAN: +5.91% · DSGX: -4.5%
6M Horizon CWAN +33.9 pp
CWAN: +9.62% · DSGX: -24.28%
1Y Horizon CWAN +33.33 pp
CWAN: +18.7% · DSGX: -14.63%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CWAN vs DSGX. Trailing 12-month operating profitability (CWAN 4.1% vs DSGX 32.0%) and valuation multiples (CWAN 94.5x vs DSGX 34.2x Forward P/E) are benchmarked directly in Pillar 4 below.

CWAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$826M
Gross Margin66.0%
Op. Margin4.1%
ROE / Fwd P/E-3.1% · 94.5x
DSGX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$775M
Gross Margin77.6%
Op. Margin32.0%
ROE / Fwd P/E11.9% · 34.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CWAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 0.8%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact CWAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DSGX CONSOLIDATION
26d in phase · OBV DISTRIBUTION
Current IV 42.6%
IV Percentile 13th %ile
Put/Call OI Skew 0.20x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact DSGX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CWAN Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $7.3B market capitalization and 4.1% operating margin.
OpEx & R&D Reinvestment 61.9% of Rev ($511M)
90D Engineering Disclosures 0 Published
DSGX Moat Profile High-Margin Pricing Power Moat
Software - Application Operator
Competes within the Software - Application value chain with $7.7B market capitalization and 32.0% operating margin.
OpEx & R&D Reinvestment 45.6% of Rev ($353M)
90D Engineering Disclosures 0 Published

Investor FAQ CWAN vs DSGX Key Questions & Quantitative Answers

As of Nov 20, 2026, Clearwater Analytics Holdings, Inc. (CWAN) is the stronger overall head-to-head candidate over Descartes Systems Group Inc (DSGX) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning, R&D & Supply-Chain Moat). CWAN carries a Unified Composite Score of 63.2/100 (BUY) at $24.56 (94.5x Forward P/E, 4.1% operating margin), whereas DSGX carries 40.1/100 (SELL) at $89.20 (34.2x Forward P/E, 32.0% operating margin). Technically, CWAN sits in a Markup phase (RSI 67.9, UNCLASSIFIED options structure) and DSGX sits in a Neutral phase (RSI 45.6, CONSOLIDATION options structure).

CWAN leads the Growth & Scale pillar: CWAN posts +74.4% YoY revenue growth and +202.8% YoY earnings growth on $826M TTM revenue (66.0% gross margin, 4.1% operating margin), compared with DSGX at +11.8% YoY revenue growth and +32.6% YoY earnings growth on $775M TTM revenue (77.6% gross margin, 32.0% operating margin). On trailing 12-month operating scale, CWAN generates $826M in USD-normalized revenue versus $775M for DSGX. In operating R&D and SG&A reinvestment, CWAN deploys 61.9% of Rev ($511M) (0 90-day corporate R&D disclosures) versus 45.6% of Rev ($353M) (0 disclosures) for DSGX.

DSGX screens cheaper on headline valuation multiples. CWAN trades at 94.5x Forward P/E, 35.6x Trailing P/E, 1.78x PEG, and 8.9x EV/Revenue (13.2% EBITDA margin), whereas DSGX trades at 34.2x Forward P/E, 41.8x Trailing P/E, 1.53x PEG, and 9.4x EV/Revenue (38.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CWAN (-3.1% ROE) versus DSGX (11.9% ROE) capital efficiency.

In options market volatility and institutional positioning, CWAN carries 0.8% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.42β · 4% Vol realized risk). By comparison, DSGX carries 42.6% implied volatility (13th %ile, Compressed (<25th %ile)), a 0.20x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.27β · 23% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.